Navigation Links
AtheroNova Receives Notice of Issuance of Its U.S. Patent 8,304,383
Date:11/15/2012

y company focused on the discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits and to safely improve lipid profiles in humans. In addition to its lead compound AHRO-001, AtheroNova plans to develop multiple applications for its patents-pending therapies in market sectors that include: Cardiovascular Disease, Stroke, Peripheral Artery Disease, Dementia and Alzheimer's and Erectile Dysfunction, all of which have been linked to atherosclerosis. Atherosclerosis and its related pharmaceutical expenses for these indications cost consumers more than $41 billion annually in the United States alone. For more information, please visit www.AtheroNova.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the suitability of the compound for its intended use, mechanisms of action, intellectual property as well as the development of applications for AtheroNova's technology. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as significant fluctuations in expenses associated with clinical trials, failure to secure additional financing, the inability to complete regulatory filings with the Food and Drug Administration, the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in AtheroNova's filings with the United States Securities and Exchange
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AtheroNova Names New Director
2. AtheroNova to Present at Rodman & Renshaw 14th Annual Healthcare Conference in New York City
3. AtheroNova Releases 2011 Financial Results
4. AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001
5. AtheroNova Announces a New Board Member
6. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
7. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
8. Ceres Receives $3.5 million from USAID for Trait Stacks
9. Creabilis Receives Prestigious Technology Strategy Board Biomedical Catalyst Award
10. Hertz Fellow, Grant I. Gillary, Receives Hertz Foundation-George Lerman Fellowship
11. Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Oct. 30, 2014  Ardelyx, Inc. (NASDAQ: ... on cardio-renal, gastrointestinal and metabolic diseases, today announced ... results on Thursday, November 6, 2014. Following the ... live conference call and webcast at 4:30pm ET ... a business update. The live webcast ...
(Date:10/30/2014)... Texas (PRWEB) October 30, 2014 ... Naltrexone HCL Industry” is a professional and in-depth ... report provides basic Naltrexone HCL information, including its ... well as industry overview. This research covers the ... well as global industry analysis covering macroeconomic environment ...
(Date:10/30/2014)... October 30, 2014 SoundConnect ... provider, offers Office 365 end users the key ... complete phone system by adding voice enablement and ... includes Lync Online, a communication tool that includes ... With hosted voice, O365 becomes a comprehensive unified ...
(Date:10/30/2014)... MA (PRWEB) October 30, 2014 James Sherley ... advance in adult tissue stem cell technology since his days ... (FCCC) in Philadelphia in the late 1990’s. Sherley founded ... The company holds all the intellectual property developed in ... professor at the Massachusetts Institute of Technology (MIT), and more ...
Breaking Biology Technology:Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 3SoundConnect Launches Voice Enablement and Hybrid Audio Conferencing for Office 365 2SoundConnect Launches Voice Enablement and Hybrid Audio Conferencing for Office 365 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4
... Varian, Inc.,(NasdaqGS: VARI) today announced a plan to ... to close certain facilities. , ... economic environment,we are taking proactive steps to reduce our ... while continuing to invest in new product,development and maintaining ...
... Associates, Inc.,(SullivanCotter) has published its 16th 2008 Physician ... Notable findings this year,include an average salary increase ... physicians. Nearly three-quarters (72%) of the survey,participants ... 2008,which is comparable to last year, when 73% ...
... have entered into a research collaboration to improve insect control in ... ... Research Triangle Park, NC (Vocus) January 15, 2009 -– DuPont and ... improve insect control in corn and soybeans. Under the agreement, ...
Cached Biology Technology:Varian, Inc. Announces Cost Reduction Plan 2Despite Economic Woes, Physician Compensation Increases 2Despite Economic Woes, Physician Compensation Increases 3DuPont and Athenix Collaborate to Advance Insect Control in Corn, Soybeans 2DuPont and Athenix Collaborate to Advance Insect Control in Corn, Soybeans 3
(Date:10/28/2014)... awards to expand the Office of Rare Diseases ... Translational Sciences (ORDR-NCATS) collaborative Rare Diseases Clinical Research ... at 22 consortia will work with 98 patient ... new treatments for patients with rare diseases. The ... fiscal 2014 funding from NIH. , Rett syndrome, ...
(Date:10/28/2014)... will be building a hybrid micro-grid which will ... first in the region, the hybrid micro-grid will ... tidal-current, diesel, storage and power-to-gas technologies, and ensure ... be built under the new Renewable Energy Integration ... be located offshore at Semakau Landfill and is ...
(Date:10/27/2014)... are an indigenous species of the West Antarctic Peninsula ... Earth. Since 1950, the average annual temperature in the ... and 6 degrees Celsius during winter. , As ... dry, polar system to a warmer, sub-polar system with ... a connection between local weather conditions and the weight ...
Breaking Biology News(10 mins):NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 2NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 3NTU to build region's first renewable energy integration demonstration micro-grid 2NTU to build region's first renewable energy integration demonstration micro-grid 3University of Delaware study connects penguin chick weights to local weather conditions 2University of Delaware study connects penguin chick weights to local weather conditions 3
... Human Genome Research Institute (NHGRI), one of the National ... Sequencing Research Network will target 13 more organisms as ... that will expand biological knowledge and improve human health. ... (NACHGR), which is a federally chartered committee that advises ...
... proteins have evolved, UT Southwestern Medical Center researchers have ... to use to design proteins, rules the scientists have ... function just like their natural counterparts. , In two ... journal Nature, Dr. Rama Ranganathan, associate professor of pharmacology, ...
... swat a fly? The fly's secret in avoiding death in ... to fly out of the way. "This kind of low-power ... robots", according to Gwyneth Card of the California Institute of ... response at the Society for Experimental Biology Annual Main Meeting ...
Cached Biology News:NHGRI Selects 13 More Organisms for Genome Sequencing 2NHGRI Selects 13 More Organisms for Genome Sequencing 3NHGRI Selects 13 More Organisms for Genome Sequencing 4NHGRI Selects 13 More Organisms for Genome Sequencing 5Researchers create functioning artificial proteins using nature's rules 2Researchers create functioning artificial proteins using nature's rules 3
Preparation TW--Compatibility: no end cap seals -Hybridization Tube for Hybrigene -Comp Dim: 240 80 mm -Material: borosilicate glass -Mfr Desig: Techne FHB-15...
...
... For use in hybridization incubators ... and GL 45 size PP plug-seal ... seal. Available in three lengths to ... plug-seal caps and O-rings available separately. ...
... extraction of DNA from agarose gels The SpinPrep ... of 150 bp to > 12,000 bp in size ... dissolve the gel slice, followed by adsorption of the ... format. After a wash step, the purified DNA is ...
Biology Products: